By charging drug companies 'user fees' that will be spent hiring new staff, the US Food and Drug Administration will reduce the time it takes to review new pharmaceuticals from an average of two years to one.
Rights and permissions
About this article
Cite this article
New drug law to speed scientific review. Nature 359, 563 (1992). https://doi.org/10.1038/359563a0
Issue Date:
DOI: https://doi.org/10.1038/359563a0
